SARA ZIGHELBOIM: Open Payments
NPI 1609400944 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 9 payments from 6 companies in 2025. Trend: 2023 $118 · 2024 $181 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $78 |
| Novo Nordisk Inc | 2 | $40 |
| Myriad Genetic Laboratories, Inc. | 1 | $26 |
| Boston Scientific Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: ELIQUIS, PROLARIS, AMS 800 Artificial Urinary Sphincter, Ozempic, MOUNJARO, Wegovy, SHINGRIX.
Industry payments across FL — which companies pay providers there.
